Antharis Therapeutics is a biopharmaceutical company developing new treatments for cancer and neurological disorders, as well as in infectious and inflammatory diseases. Our company uses cutting-edge science to develop therapeutic monoclonal antibodies and antibody-drug conjugates with the end goal of treating unmet medical needs.
We use an array of cutting-edge scientific approaches, including unbiased large-scale screening methods, that uniquely allow for biology and disease to instruct us on relevant therapeutic targets. In addition, our distinctive methodologies increase significantly the efficiency with which our team develops innovative antibody therapies that can rapidly enter the clinic to benefit patients.
Antharis is a vibrant, young and innovative company with a passion to develop treatments for devastating diseases for which there are no satisfactory therapies available. Defeating these diseases requires a diverse and skilled team, which we are constantly looking to expand.